i've been looking at the phase1 data, does anyone see anything strange in this130week graph, page-3

can't give a test to investors!!

so here's what i observe:
1. why did LCT stop showing individual scores at week 130 and only averages?
2. what happened between weeks 84 and week 108(?) that caused all or some patients to get worse? it would have been very interesting to see if a all 4 patients got worse. another graph has the results for patient 1 at 130 weeks with an amazing -32 improvement.
https://www.otcmarkets.com/ajax/showNewsReleaseDocumentById.pdf?id=24250

keep in mind that patient 1 got her implant (i think it's a her) about a year before patient2 and patient's 3&4 about a month after patient2 so they weren't evaluated on the same day. so were there any differences in how they were evaluated? did they reduce their meds anytime during the 130 weeks? did they increase their meds? how did they ensure patients took no meds before being evaluated? with so few datapoints it would only take a few occasions where a patient was only slightly medicated to skew the exam results.
3. there was almost no change between weeks 26 and 82 then the avg score went from -8 to -3???? then it got better? just too much variability for me. just food for thought.

4. if their endpoint was at week 60, -7 vs -10 at week 26, would the results have statistically significant?